Concord Medical Services
3 hedge funds and large institutions have $249K invested in Concord Medical Services in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less capital invested
Capital invested by funds: $312K → $249K (-$63K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$24.3K |
CCM Hedge Fund Activity: Q1 2022 in Review
3 of the 6,359 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q1 2022, worth a combined $249K — down 20% from $312K a quarter earlier.
Fund positioning in CCM was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $3.72K. The largest seller was Renaissance Technologies, cutting an estimated $24.3K.
- 3 institutional investors held Concord Medical Services (CCM) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $249K of Concord Medical Services stock for Q1 2022, down 20% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q1 2022 and 0 closed out.
- The largest Concord Medical Services buyer in Q1 2022 was UBS Group, an estimated $3.72K added.
- The largest Concord Medical Services seller in Q1 2022 was Renaissance Technologies, an estimated $24.3K sold.
Based on aggregated 13F filings for Q1 2022.